Cell-Free DNA (cfDNA): Market Size and Share Analysis (Consumables, Systems, Services)

 Cell-Free DNA (cfDNA) Markets details the market opportunity for cfDNA analysis instruments, consumables, kits, and related software. The report provides complete market information, including current market estimates and forecasts to 2021, as well as:
  • Growth Rate for cfDNA Market, 2016-2021
  • cfDNA Clinical Diagnostics Market, 2016-2021
  • cfDNA Clinical Diagnostics Market Growth Rate, 2016-2021
  • cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW)
  • cfDNA Instruments and Consumables Revenues by Product Type, 2016 (Consumables, Systems, Services)
  • Market Share by Company of the cfDNA Analysis Instruments, Consumables, and Software Market, 2016
The report provides information on cfDNA analysis products, commenting not only on reagents, consumables, kits, systems, software, and services, but also on oncology cfDNA products, cfDNA transplantation diagnostics, and other products employing cfDNA.

In the cfDNA market there are many technical challenges to overcome, along with a range of competitive, regulatory, and IP issues. Cancer is a dynamic and defiant disease. While NIPT is a proven application, oncology will require much more difficult work and is more uncertain. The variety of potential issues and threats in the market are covered in the challenges and strategic recommendations chapter of the report. The competitive situation, deals, and litigation are covered in respective chapters as well.

Cell-Free DNA (cfDNA) Markets covers not just the dynamics of the market but also its competitive landscape. For example, several companies are licensing their technologies or offering services. The report profiles those companies competing in the cfDNA instruments and consumables market, including:
  • Agilent Technologies
  • Bio-Rad
  • F. Hoffmann-La Roche AG
  • Fluidigm
  • Illumina
  • Qiagen
  • RainDance Technologies
  • Thermo Fisher Scientific
The report was produced through a combination of primary research, secondary research, and internal databases, including SEC filings, product literature, corporate websites, conferences, journals, and trade publications.


  • Executive Summary
    • NIPT, Oncology Leading Market Forward
    • Sensitivity Benefits of dPCR, qPCR, NGS
    • Challenges, Biological and Technologies Limitations
    • Scope and Methodology
  • Introduction
    • NIPT Companies, Others Shifting Strategies to Cancer
    • Expanding Clinical Adoption Sustains High Growth
    • Government Initiatives -- Cancer Moonshot, Blood Profiling Atlas
    • Mergers, Acquisitions, Equity Investments Increasing
    • China Becoming Major Player in Market
    • Personalized, Proactive Medicine Gaining Momentum
    • Expected Sequencer Platforms Stalled or Cancelled
    • Significant Efforts in Automation, Miniaturization
    • Regulatory Situation Unclear But Evolving Somewhat
  • cfDNA Analysis Products
    • cfDNA Reagents, Consumables, and Kits
      • Table cfDNA Reagents, Consumables, and Kits
    • cfDNA Systems and Software
      • Table cfDNA Systems and Software
    • cfDNA NIPT Products and Services
      • Table cfDNA NIPT Products and Services
    • cfDNA in Oncology, Transplantation and Other Diseases
      • Table Oncology cfDNA Products
      • Table cfDNA Transplantation Diagnostics
    • cfDNA Other Products
      • Table cfDNA Other Products
    • Recent Product/ Service Introductions
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
  • Market Analysis
    • Revenues Forecast
      • Table Cost of Sequencing a Genome
    • Market Size and Forecast
      • Table Market for cfDNA, 2015-2021
      • Table cfDNA Market, 2015-2021 ($M)
      • Table Growth Rate for cfDNA Market, 2015-2021
      • Table Growth Rate in cfDNA Market, 2016-2020
    • cfDNA Clinical Diagnostics Market
      • Table cfDNA Clinical Diagnostics Market, 2015-2021 ($M)
      • Table cfDNA Clinical Diagnostics Market Growth Rate, 2015-2021
    • cfDNA Market by Region
      • Table cfDNA Market by Region, 2015 (N. America, Europe, Asia-Pacific & ROW)
      • Table cfDNA Market by Region, 2015 (%) (N. America, Europe, Asia-Pacific & ROW)
    • Revenues by Product Type
      • Table cfDNA Instruments and Consumables Revenues by Product Type, 2015 (Consumables, Systems/hardware, Services)
      • Table Breakout of cfDNA Market by Type (Consumables, Systems/hardware, Services)
    • Illumina Sequencing Revenues as Indicator
      • Table Illumina Quarterly Sequencing Revenues (2012-2016)
      • Table Illumina Quarterly Consumables Revenues (2012-2016)
      • Table Illumina Annual Consumables Revenues (2012-2015)
      • Table Illumina Consumables Growth Rates (2013-2015)
  • cfDNA Instruments and Consumables Competitive Analysis
    • Introduction
    • cfDNA Instruments and Consumables Market Shares
      • Table Market Shares by Company of the cfDNA Analysis Instruments, Consumables, and Software Market, 2015
      • Table cfDNA Instruments and Consumables Market Share by Company, 2015 (%)
  • Intellectual Property and Litigation
    • Sequenom, Several NIPT Companies Fighting
    • Ariosa Diagnostics (Roche) Files Suit Against Sequenom
    • Natera Sues Sequenom; Sequenom Sues Natera
    • Verinata Health and Stanford File Against Sequenom
    • Verinata Health Against Ariosa and LabCorp
    • Illumina Sues Ariosa Diagnostics for NIPT Test
    • Illumina Sues Premaitha Health for NIPT Test
    • Illumina Sues Premaitha and Ariosa Partners
    • Sequenom and Illumina Settle and Pool Patents
    • Sequenom Petitions Supreme Court
    • Illumina Sues Qiagen for GeneReader System
    • llumina's Conflicts with Oxford Nanopore
    • Enzo Biochem Brings Suit Against Numerous Companies
    • 454 (Roche) Sues Ion Torrent (Thermo Fisher)
    • RainDance Technologies Sues 10X Genomics
    • 10X Genomics' Dispute with Bio-Rad
    • Sequenom Shareholder Sues Over Price "Capping"
    • Helicos' Patent Infringement Suit Against PacBio, Life Technologies, and Illumina
    • Illumina's Two Lawsuits Against Complete Genomics for Infringement
    • Life Technologies and Illumina Dispute Over Amplification on Solid Surfaces
    • Enzo Biochem Disputes Sequencing Patents
    • LabCorp's Esoterix Sues Life Technologies
    • Genetic Technologies Sues Several Firms for Infringement of Haplotype Determination Technique
  • cfDNA Analysis Market Deals
    • The Significant Collaborations
      • Table cfDNA Analysis Market Deals
  • cfDNA Instruments and Consumables Market Corporate Profiles
    • Agilent Technologies
    • Bio-Rad
    • F. Hoffmann-La Roche AG
    • Fluidigm
    • Illumina
    • Qiagen
    • RainDance Technologies
    • Thermo Fisher Scientific
  • Challenges and Strategic Recommendations
    • Challenges
    • Strategic Recommendations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings